Heart transplant vaccine study halted after just 4 patients
NCT ID NCT04845945
First seen Feb 04, 2026 · Last updated Jun 08, 2026 · Updated 16 times
Summary
This study aimed to see how well heart transplant candidates and recipients respond to the standard pneumococcal vaccine using two different blood tests. Only 4 adults were enrolled before the study was stopped early. The goal was to check antibody levels, but no conclusions can be drawn due to the small size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center, Infectious Diseases
The Bronx, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.